Pfizer Inc. PFE
$25.96▲ +0.15% 24H
Super Investor & Insider
8
Fondi che lo detengono
#64
Rank consenso
11.4%
% dei portafogli
$351.9M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Richard Pzena · Pzena Investment Management | 0.54% | Reduce 9.22% | 5,924,892 | $166.4M |
| Harry Burn · Sound Shore Management | 2.7% | Buy | 2,870,421 | $80.6M |
| Sarah Ketterer · Causeway Capital Management | 0.66% | Reduce 8.49% | 1,914,219 | $53.8M |
| Prem Watsa · Fairfax Financial Holdings | 1.43% | Add 11.22% | 990,900 | $27.8M |
| Kahn Brothers Group · Kahn Brothers Group | 2.41% | Reduce 12.5% | 484,733 | $13.6M |
| Hillman Capital Management · Hillman Capital Management | 3.66% | Add 7.21% | 187,937 | $5.3M |
| Dodge & Cox · Dodge & Cox | 0% | Reduce 1.99% | 88,564 | $2.5M |
| Mairs & Power · Mairs & Power | 0.02% | Reduce 2.83% | 71,829 | $2.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Pfizer Inc. is a leading biopharmaceutical company that discovers, develops, manufactures, markets, distributes, and sells prescription drugs and vaccines worldwide. Operating in segments including Biopharma, PC1, and Pfizer Ignite, it focuses on key therapeutic areas such as oncology, cardiology, immunology, and infec…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees75,000
TickerPFE
Statistics
Market Cap$147.97B
Revenue (TTM)$62.58B
Net Income$7.77B
Net Margin12.4%
EPS$1.36
P/E19.98
P/S2.36
P/B1.66
EV/EBITDA7.77
ROE8.3%
Dividend Yield6.56%
Price$25.96
Data: Twelve Data · Revenue = mcap / P/S